Stock listing

Lang & Schwarz:A1JH3B Egetis Therapeutics AB Aktie

German listing (Lang & Schwarz) of Egetis Therapeutics AB · home listing Stockholm:EGTX

Follow Egetis Therapeutics AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:EGTX

11.12 SEK -0.02 (-0.2%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:EGTX

Past year +110.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
11.12 – 11.14 SEKNov 20, 2026
Volume
1.81M sharesNov 20, 2026
Market cap
5.17B SEKAt the close on Nov 20, 2026 · price × 465.0M shares outstanding
52-week range
3.63 – 11.20 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
29.35M SEKMedian day 1.56M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Egetis Therapeutics AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:EGTX · Home11.12 SEK-0.02 (-0.2%)1,812,09911.1211.1411.1211.14Close on Nov 20, 2026
LSE:0ABW11.14 SEK+0.01 (+0.1%)255,26211.1411.1511.1311.13Close on Nov 20, 2026
Frankfurt:P0F€0.96 EUR-0.008 (-0.8%)—€0.964€0.964€0.96€0.968Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:EGTX · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
11.12-0.02-0.2%11.1211.1411.121,812,099
11.14+0.02+0.2%11.1211.1611.122,690,533
11.120.000.0%11.1211.1411.122,094,421
11.12-0.08-0.7%11.1411.1811.121,675,544
11.20+0.08+0.7%11.1011.2011.102,233,894
11.120.000.0%11.1211.1411.102,472,472
11.120.000.0%11.1011.1811.105,182,684
11.120.000.0%11.1011.1611.108,736,542
11.12+1.13+11.3%11.0611.1611.0633,187,786
9.99+0.05+0.5%10.0010.249.444,646,145
9.94-0.01-0.1%9.919.969.60953,031
9.95-0.11-1.1%10.0610.109.771,431,166
10.06-0.28-2.7%10.3410.4810.001,029,096
10.340.000.0%10.3210.8210.261,992,167
10.34+0.57+5.8%9.8110.429.703,598,040
9.77+0.52+5.6%9.289.799.242,094,612
9.25+0.19+2.1%9.119.349.081,229,759
9.06-0.18-1.9%9.229.228.961,510,430
9.24-0.33-3.4%9.469.509.201,196,900
9.57+0.40+4.4%9.189.579.101,016,605
9.17+0.10+1.1%9.029.269.001,607,727
9.07-0.17-1.8%9.269.369.002,075,949
9.24+0.03+0.3%9.219.459.211,075,660
9.21-0.24-2.5%9.509.539.112,099,877
9.45-0.15-1.6%9.639.689.302,183,842
9.60-0.35-3.5%9.9010.069.602,349,030
9.95+0.02+0.2%9.9210.109.801,980,498
9.93+0.08+0.8%9.9710.089.752,212,439
9.85+0.31+3.2%9.6610.149.454,254,187
9.54-0.02-0.2%9.359.789.254,158,483
9.56+0.50+5.5%9.159.619.134,008,629
9.06-0.12-1.3%9.189.388.953,737,929
9.18-0.26-2.8%9.459.689.146,060,584
9.44+0.58+6.5%8.889.478.819,704,484
8.86+0.43+5.1%8.549.108.448,160,852
8.43+0.99+13.3%8.479.098.2230,201,271
7.44-0.44-5.6%7.918.007.362,232,918
7.88+0.17+2.2%7.727.997.542,378,572
7.71-0.08-1.0%7.807.957.591,122,836
7.79-0.15-1.9%7.947.957.65659,437
7.94+0.34+4.5%7.647.967.60854,144
7.60-0.31-3.9%8.008.007.432,254,925
7.91-0.09-1.1%8.048.307.901,826,613
8.00+0.12+1.5%7.948.047.87508,682
7.88+0.01+0.1%7.927.957.80529,098
7.87-0.09-1.1%7.968.187.87689,813
7.96+0.07+0.9%8.008.047.89524,614
7.89-0.16-2.0%8.078.107.87505,531
8.05-0.01-0.1%8.008.207.951,173,584
8.06+0.07+0.9%7.988.067.90811,835
7.99+0.34+4.4%7.557.997.55919,513
7.65-0.05-0.6%7.737.827.50717,128
7.70-0.14-1.8%7.907.977.62636,574
7.84+0.07+0.9%7.828.057.82567,811
7.77-0.12-1.5%7.908.067.75558,715
7.89+0.04+0.5%7.868.047.71957,098
7.85-0.15-1.9%8.088.207.851,012,317
8.00-0.04-0.5%8.038.147.94904,285
8.04+0.04+0.5%7.958.047.451,143,835
8.00+0.13+1.7%7.868.157.731,317,378
7.87+0.36+4.8%7.497.877.451,437,262
7.51+0.18+2.5%7.357.647.201,225,791
7.33+0.53+7.8%6.967.376.961,515,701
6.80-0.14-2.0%7.007.006.73574,661
Ticker
Lang & Schwarz:A1JH3B
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Egetis Therapeutics (Stockholm:EGTX) Q2 2026 Earnings Call

    Fri, Aug 21, 2026 · 8:00 AM ET

    Watch Transcript
  • Egetis Therapeutics (Stockholm:EGTX) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 4:00 AM ET

    Watch Transcript

Latest news

All Egetis Therapeutics AB news

Financings

  • Private placement of new ordinary shares

    Apr 21, 2026 · US$38.2M

    Closed: SEK 350M raised · SEK 5.25 a share · Stifel +2

    Dealers: Stifel (lead), Van Lanschot Kempen (co-lead), DNB Carnegie (co-lead)

    Buyers: Frazier Life Sciences (expected to anchor the Directed Issue); Invus; Woodline Partners; Parkman Healthcare Partners; Linc AB; The Fourth Swedish National Pension Fund; Cidro Förvaltning AB (Peter Lindell); Unionen

    Use of proceeds: Preparing Emcitate U.S. commercialization, RTH-beta indication expansion, working capital and general corporate purposes

    Announced Apr 21, 2026 · Closed Apr 21, 2026

Read by 6ix AI from the company's releases

Decks

Egetis Therapeutics AB on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
18 in the last 12 months · 18 in all · newest Sep 29, 2026 · oldest 2026
Calls
2 calls with a replay · 2 with a transcript · latest Aug 21, 2026
Decks
37 decks · latest October 2026

Where Egetis Therapeutics AB is listed

ListingExchangeCountryCurrency
Stockholm:EGTX · Home listingStockholmSwedenSEK
LSE:0ABWLSEUnited KingdomSEK
OTC:PDPHFOTCUnited StatesUSD
Lang & Schwarz:A1JH3B · This pageLang & SchwarzGermanyEUR
LS Exchange:A1JH3BLS ExchangeGermanyEUR
Frankfurt:P0FFrankfurtGermanyEUR
Aquis:EGTXSAquisUnited KingdomSEK
gettex:P0FgettexGermanyEUR
Aquis:EGTXSAquisUnited KingdomSEK
Munich:P0FMunichGermanyEUR
Stuttgart:P0FStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Egetis Therapeutics AB.